0001654954-24-000770.txt : 20240119 0001654954-24-000770.hdr.sgml : 20240119 20240119163025 ACCESSION NUMBER: 0001654954-24-000770 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20240118 ITEM INFORMATION: Other Events FILED AS OF DATE: 20240119 DATE AS OF CHANGE: 20240119 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TENAX THERAPEUTICS, INC. CENTRAL INDEX KEY: 0000034956 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 262593535 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-34600 FILM NUMBER: 24545992 BUSINESS ADDRESS: STREET 1: 101 GLEN LENNOX DRIVE STREET 2: SUITE 300 CITY: CHAPEL HILL STATE: NC ZIP: 27517 BUSINESS PHONE: 919-855-2100 MAIL ADDRESS: STREET 1: 101 GLEN LENNOX DRIVE STREET 2: SUITE 300 CITY: CHAPEL HILL STATE: NC ZIP: 27517 FORMER COMPANY: FORMER CONFORMED NAME: OXYGEN BIOTHERAPEUTICS, INC. DATE OF NAME CHANGE: 20080703 FORMER COMPANY: FORMER CONFORMED NAME: SYNTHETIC BLOOD INTERNATIONAL INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: SINEQUANON CORP DATE OF NAME CHANGE: 19901219 8-K 1 tenx_8k.htm FORM 8-K tenx_8k.htm

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): January 18, 2024

 

Tenax Therapeutics, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware

 

001-34600

 

26-2593535

(State or other jurisdiction of incorporation)

 

(Commission File Number)

 

(IRS Employer Identification No.)

 

101 Glen Lennox Drive, Suite 300 

Chapel Hill, North Carolina 27517 

(Address of principal executive offices) (Zip Code)

 

919-855-2100

(Registrant’s telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, $0.0001 par value per share

TENX

The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2).

 

Emerging growth company  

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ☐

 

 

 

 

Item 8.01 Other Events. 

 

On January 18, 2024, Tenax Therapeutics, Inc. (the “Company”) received written notification from the Nasdaq Stock Market LLC (“Nasdaq”) confirming that the Company’s common stock had a closing price of $1.00 or greater for the ten consecutive trading days from January 3, 2024 to January 17, 2024 and that as a result the Company had regained compliance with Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Rule”) and that the matter is now closed.

 

As previously reported, on March 29, 2023, Nasdaq notified the Company that for the last 30 consecutive business days, the bid price for the Company’s common stock had closed below the minimum $1.00 per share requirement for continued inclusion on the Nasdaq Capital Market pursuant to the Bid Price Rule. On September 28, 2023, the Company received formal notice that Nasdaq had granted the Company’s request for an extension through March 25, 2024 to evidence compliance with the Bid Price Rule.

 

 

2

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: January 19, 2024

Tenax Therapeutics, Inc.

 

 

 

 

 

 

By:

/s/ Christopher T. Giordano 

 

 

Christopher T. Giordano

 

 

President and Chief Executive Officer

 

 

 

3

EX-101.SCH 2 tenx-20240118.xsd XBRL TAXONOMY EXTENSION SCHEMA 000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 3 tenx-20240118_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Entity Registrant Name Entity Central Index Key Document Type Amendment Flag Entity Emerging Growth Company Document Period End Date Entity File Number Entity Incorporation State Country Code Entity Tax Identification Number Entity Address Address Line 1 Entity Address Address Line 2 Entity Address City Or Town Entity Address State Or Province Entity Address Postal Zip Code City Area Code Local Phone Number Security 12b Title Trading Symbol Security Exchange Name Written Communications Soliciting Material Pre Commencement Tender Offer Pre Commencement Issuer Tender Offer EX-101.CAL 4 tenx-20240118_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.PRE 5 tenx-20240118_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE EX-101.DEF 6 tenx-20240118_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE XML 7 R1.htm IDEA: XBRL DOCUMENT v3.23.4
Cover
Jan. 18, 2024
Cover [Abstract]  
Entity Registrant Name Tenax Therapeutics, Inc.
Entity Central Index Key 0000034956
Document Type 8-K
Amendment Flag false
Entity Emerging Growth Company false
Document Period End Date Jan. 18, 2024
Entity File Number 001-34600
Entity Incorporation State Country Code DE
Entity Tax Identification Number 26-2593535
Entity Address Address Line 1 101 Glen Lennox Drive
Entity Address Address Line 2 Suite 300
Entity Address City Or Town Chapel Hill
Entity Address State Or Province NC
Entity Address Postal Zip Code 27517
City Area Code 919
Local Phone Number 855-2100
Security 12b Title Common Stock, $0.0001 par value per share
Trading Symbol TENX
Security Exchange Name NASDAQ
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
XML 8 tenx_8k_htm.xml IDEA: XBRL DOCUMENT 0000034956 2024-01-18 2024-01-18 iso4217:USD shares iso4217:USD shares 0000034956 false 8-K 2024-01-18 Tenax Therapeutics, Inc. DE 001-34600 26-2593535 101 Glen Lennox Drive Suite 300 Chapel Hill NC 27517 919 855-2100 false false false false Common Stock, $0.0001 par value per share TENX NASDAQ false EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.4 html 1 23 1 false 0 0 false 3 false false R1.htm 000001 - Document - Cover Sheet http://tenx.com/role/Cover Cover Cover 1 false false All Reports Book All Reports tenx-20240118.xsd tenx-20240118_cal.xml tenx-20240118_def.xml tenx-20240118_lab.xml tenx-20240118_pre.xml tenx_8k.htm http://xbrl.sec.gov/dei/2023 true true JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "tenx_8k.htm": { "nsprefix": "tenx", "nsuri": "http://tenx.com/20240118", "dts": { "schema": { "local": [ "tenx-20240118.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/currency/2023/currency-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/exch/2023/exch-2023.xsd", "https://xbrl.sec.gov/naics/2023/naics-2023.xsd", "https://xbrl.sec.gov/sic/2023/sic-2023.xsd", "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd" ] }, "calculationLink": { "local": [ "tenx-20240118_cal.xml" ] }, "definitionLink": { "local": [ "tenx-20240118_def.xml" ] }, "labelLink": { "local": [ "tenx-20240118_lab.xml" ] }, "presentationLink": { "local": [ "tenx-20240118_pre.xml" ] }, "inline": { "local": [ "tenx_8k.htm" ] } }, "keyStandard": 23, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 24, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 23 }, "report": { "R1": { "role": "http://tenx.com/role/Cover", "longName": "000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "From2024-01-18to2024-01-18", "name": "dei:EntityRegistrantName", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "strong", "p", "td", "tr", "tbody", "table", "body", "html" ], "reportCount": 1, "baseRef": "tenx_8k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-18to2024-01-18", "name": "dei:EntityRegistrantName", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "strong", "p", "td", "tr", "tbody", "table", "body", "html" ], "reportCount": 1, "baseRef": "tenx_8k.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://tenx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://tenx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://tenx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://tenx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address Address Line 2", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://tenx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://tenx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address City Or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://tenx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://tenx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://tenx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://tenx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://tenx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address Address Line 1", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://tenx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://tenx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://tenx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation State Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://tenx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://tenx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre Commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://tenx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://tenx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre Commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://tenx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://tenx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://tenx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address State Or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://tenx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://tenx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security 12b Title", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 15 0001654954-24-000770-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001654954-24-000770-xbrl.zip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